Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
Neurology|January 10, 2001
Clinical and spectroscopic improvement in HIV-associated cognitive impairmentB Stankoff, A Tourbah, S Suarez, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2016
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemiaC Katlama, C Soulié, F Caby, et al.
Annales De Dermatologie Et De Venereologie|January 2, 2018
Anaplastic Kaposi's sarcoma: 5 cases of a rare and aggressive type of Kaposi's sarcomaM Chapalain, G Goldman-Lévy, N Kramkimel, et al.
Annals of Internal Medicine|October 3, 1998
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infectionC Katlama, M A Valantin, S Matheron, et al.
AIDS Research and Human Retroviruses|January 12, 2001
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatmentM Burgard, J Izopet, B Dumon, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2020
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrationsR Palich, M Wirden, G Peytavin, et al.
Pathologie-Biologie|August 19, 2000
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T]M Mouroux, J Izopet, D Descamps, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitorsB Masquelier, E Race, C Tamalet, et al.
Targeted Oncology|July 26, 2015
Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanomaN Kramkimel, A Thomas-Schoemann, L Sakji, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2014
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept studyS Seang, S Fourati, Y Keita, et al.
Pageof 20